Ignite Creation Date:
2025-12-24 @ 7:52 PM
Ignite Modification Date:
2026-02-25 @ 8:18 PM
Study NCT ID:
NCT00500604
Status:
COMPLETED
Last Update Posted:
2010-07-19
First Post:
2007-07-11
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy of Irbesartan/Hydrochlorothiazide Versus Valsartan/Hydrochlorothiazide in Mild to Moderate Hypertension
Sponsor:
Sanofi
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
IRBEH_R_02584
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Medical Affairs Study Director
Old Organization:
sanofi-aventis